Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer

Dr Kaklamani talks to ecancertv at SABCS 2015 about a pooled analysis of five phase II studies showing that homologous recombination deficiency predicts response to neo-adjuvant platinum-based therapy in patients with triple-negative breast…

from #ORL-AlexandrosSfakianakis via simeraentaxei on Inoreader http://ift.tt/1QJLDwe
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1NNpJC9
via IFTTT